Affinity Asset Advisors, LLC Portfolio Holdings
Q3 2025•78 long positions•$983.0M portfolio value
We use cookies for analytics. See our Privacy and Cookie Policy.
Choose which columns to filter the table by
Choose which columns to display in the table
Holding87 | Sector | Position↕ | Traded↕ | Ownership↕ | Shares Δ↕ | Shares Δ % | Market Cap↕ | Owned Since↕ |
|---|---|---|---|---|---|---|---|---|
Unknown Unknown | $66.7M 6.78% | +$1.6M Bought | — 625.0K shares | 610.0K → 625.0K +$1.6M | +2.46% | — — | Q3 2024 Held for 1y 2m | |
Biotechnology Healthcare | $64.8M 6.59% | -$3.6M Sold | 0.213% 450.0K shares | 475.0K → 450.0K −$3.6M | -5.26% | $30.4B Large Cap | Q2 2024 Held for 1y 5m | |
ETF ETF | $56.3M 5.73% | +$56.3M Bought | — 84.5K shares | — | — | — — | Q1 2025 Held for 8 months | |
Biotechnology Healthcare | $56.2M 5.72% | +$12.0M Bought | 1.82% 1.4M shares | 1.1M → 1.4M +$12.0M | +27.27% | $3.1B Mid Cap | Q4 2022 Held for 2y 11m | |
Biotechnology Healthcare | $52.7M 5.37% | +$16.1M Bought | 0.516% 115.0K shares | 80.0K → 115.0K +$16.1M | +43.75% | $10.2B Large Cap | Q4 2021 Held for 3y 11m | |
Biotechnology Healthcare | $46.6M 4.74% | +$19.1M Bought | 1.97% 1.2M shares | 691.9K → 1.2M +$19.1M | +69.59% | $2.4B Mid Cap | Q3 2023 Held for 2y 2m | |
Biotechnology Healthcare | $41.1M 4.18% | +$410.5K Bought | 0.902% 500.0K shares | 495.0K → 500.0K +$410.5K | +1.01% | $4.6B Mid Cap | Q2 2022 Held for 3y 5m | |
Biotechnology Healthcare | $37.5M 3.81% | +$7.5M Bought | 0.757% 1.3M shares | 1.0M → 1.3M +$7.5M | +25.0% | $5.0B Mid Cap | Q3 2023 Held for 2y 2m | |
Biotechnology Healthcare | $33.2M 3.38% | -$2.6M Sold | 0.533% 384.4K shares | 415.0K → 384.4K −$2.6M | -7.37% | $6.2B Mid Cap | Q3 2023 Held for 2y 2m | |
Biotechnology Healthcare | $28.4M 2.89% | -$5.7M Sold | 0.967% 750.0K shares | 900.0K → 750.0K −$5.7M | -16.67% | $2.9B Mid Cap | Q1 2024 Held for 1y 8m | |
Biotechnology Healthcare | $26.9M 2.74% | +$20.3M Bought | 0.377% 285.8K shares | 70.0K → 285.8K +$20.3M | +308.24% | $7.1B Mid Cap | Q2 2024 Held for 1y 5m | |
Unknown Unknown | $26.8M 2.73% | +$5.0M Bought | — 1.1M shares | 900.2K → 1.1M +$5.0M | +23.0% | — — | Q2 2025 Held for 5 months | |
Biotechnology Healthcare | $25.7M 2.61% | +$1.9M Bought | 7.17% 3.9M shares | 3.6M → 3.9M +$1.9M | +7.83% | $358.6M Small Cap | Q1 2025 Held for 8 months | |
Biotechnology Healthcare | $25.6M 2.61% | +$2.4M Bought | 2.3% 2.8M shares | 2.5M → 2.8M +$2.4M | +10.49% | $1.1B Small Cap | Q1 2025 Held for 8 months | |
Biotechnology Healthcare | $23.8M 2.42% | +$13.6M Bought | 2.35% 1.4M shares | 606.7K → 1.4M +$13.6M | +133.95% | $1.0B Small Cap | Q4 2023 Held for 1y 11m | |
Biotechnology Healthcare | $19.7M 2.01% | -$940.0K Sold | 2.31% 2.1M shares | 2.2M → 2.1M −$940.0K | -4.55% | $853.6M Small Cap | Q1 2024 Held for 1y 8m | |
Biotechnology Healthcare | $19.2M 1.96% | +$19.2M Bought | 0.293% 350.0K shares | — | — | $6.6B Mid Cap | Q3 2025 Held for 2 months | |
Unknown Unknown | $18.4M 1.88% | +$6.8M Bought | 1.98% 959.2K shares | 603.5K → 959.2K +$6.8M | +58.94% | $930.4M Small Cap | Q3 2024 Held for 1y 2m | |
Biotechnology Healthcare | $17.5M 1.78% | +$9.6M Bought | 0.487% 300.0K shares | 135.0K → 300.0K +$9.6M | +122.22% | $3.6B Mid Cap | Q1 2025 Held for 8 months | |
Biotechnology Healthcare | $15.4M 1.56% | +$729.7K Bought | 1.32% 2.1M shares | 2.0M → 2.1M +$729.7K | +4.98% | $1.2B Small Cap | Q1 2024 Held for 1y 8m | |
Biotechnology Healthcare | $14.7M 1.49% | -$14.6M Sold | 0.355% 220.6K shares | 440.0K → 220.6K −$14.6M | -49.86% | $4.1B Mid Cap | Q4 2024 Held for 11 months | |
Biotechnology Healthcare | $13.5M 1.38% | +$13.5M Bought | 0.376% 200.0K shares | — | — | $3.6B Mid Cap | Q3 2024 Held for 1y 2m | |
Biotechnology Healthcare | $12.8M 1.3% | +$5.1M Bought | 7.65% 1.0M shares | 607.9K → 1.0M +$5.1M | +65.53% | $167.2M Micro Cap | Q1 2024 Held for 1y 8m | |
Medical - Devices Healthcare | $12.7M 1.29% | -$1.0M Sold | 1.07% 310.0K shares | 334.9K → 310.0K −$1.0M | -7.42% | $1.2B Small Cap | Q1 2021 Held for 4y 8m | |
Biotechnology Healthcare | $12.2M 1.24% | -$1.9M Sold | 5.5% 3.9M shares | 4.5M → 3.9M −$1.9M | -13.49% | $221.8M Micro Cap | Q2 2025 Held for 5 months | |
Biotechnology Healthcare | $12.1M 1.23% | +$6.1M Bought | 0.117% 800.0K shares | 400.0K → 800.0K +$6.1M | +100.0% | $10.3B Large Cap | Q1 2023 Held for 2y 8m | |
Biotechnology Healthcare | $12.0M 1.22% | -$11.2M Sold | 0.561% 500.0K shares | 970.0K → 500.0K −$11.2M | -48.45% | $2.1B Mid Cap | Q4 2024 Held for 11 months | |
Biotechnology Healthcare | $10.3M 1.05% | +$10.3M New | 0.658% 262.1K shares | 0 → 262.1K +$10.3M | New | $1.6B Small Cap | Q3 2025 Held for 2 months | |
Biotechnology Healthcare | $9.8M 0.998% | +$9.2M Bought | 1.1% 3.0M shares | 200.0K → 3.0M +$9.2M | +1,400.0% | $892.0M Small Cap | Q2 2025 Held for 5 months | |
Biotechnology Healthcare | $9.3M 0.95% | +$436.0K Bought | 1.51% 4.3M shares | 4.1M → 4.3M +$436.0K | +4.9% | $618.4M Small Cap | Q2 2024 Held for 1y 5m | |
Biotechnology Healthcare | $8.9M 0.909% | — | 1.27% 967.6K shares | — | — | $706.4M Small Cap | Q4 2022 Held for 2y 11m | |
Biotechnology Healthcare | $8.8M 0.897% | -$7.0M Sold | 0.475% 303.3K shares | 545.0K → 303.3K −$7.0M | -44.34% | $1.9B Small Cap | Q1 2024 Held for 1y 8m | |
Biotechnology Healthcare | $8.2M 0.833% | — | 0.675% 400.0K shares | — | — | $1.2B Small Cap | Q2 2025 Held for 5 months | |
Biotechnology Healthcare | $7.8M 0.796% | — | 0.244% 275.0K shares | — | — | $3.2B Mid Cap | Q2 2023 Held for 2y 5m | |
Biotechnology Healthcare | $7.8M 0.789% | +$7.8M Bought | 0.452% 300.0K shares | — | — | $1.7B Small Cap | Q3 2025 Held for 2 months | |
Biotechnology Healthcare | $7.7M 0.78% | +$214.0K Bought | 3.42% 3.6M shares | 3.5M → 3.6M +$214.0K | +2.87% | $224.4M Micro Cap | Q4 2024 Held for 11 months | |
Biotechnology Healthcare | $7.4M 0.756% | +$7.4M New | 0.296% 125.0K shares | 0 → 125.0K +$7.4M | New | $2.5B Mid Cap | Q3 2025 Held for 2 months | |
Biotechnology Healthcare | $6.7M 0.68% | +$1.4M Bought | 0.924% 2.5M shares | 2.0M → 2.5M +$1.4M | +25.64% | $723.8M Small Cap | Q1 2025 Held for 8 months | |
Biotechnology Healthcare | $6.5M 0.66% | +$978.7K Bought | 1.29% 79.5K shares | 67.5K → 79.5K +$978.7K | +17.75% | $503.9M Small Cap | Q1 2025 Held for 8 months | |
Biotechnology Healthcare | $5.5M 0.561% | +$4.6M Bought | 1.96% 1.3M shares | 223.3K → 1.3M +$4.6M | +470.6% | $281.5M Micro Cap | Q1 2024 Held for 1y 8m | |
Biotechnology Healthcare | $5.4M 0.549% | -$3.0M Sold | 0.306% 250.0K shares | 390.0K → 250.0K −$3.0M | -35.9% | $1.8B Small Cap | Q1 2023 Held for 2y 8m | |
Biotechnology Healthcare | $5.4M 0.545% | +$3.6M Bought | 0.868% 1.5M shares | 500.0K → 1.5M +$3.6M | +200.0% | $617.0M Small Cap | Q3 2023 Held for 2y 2m | |
Biotechnology Healthcare | $4.8M 0.492% | +$4.8M Bought | 0.172% 300.0K shares | — | — | $2.8B Mid Cap | Q2 2023 Held for 2y 5m | |
Biotechnology Healthcare | $4.7M 0.475% | +$4.7M New | 0.053% 100.0K shares | 0 → 100.0K +$4.7M | New | $8.7B Mid Cap | Q3 2025 Held for 2 months | |
Biotechnology Healthcare | $4.5M 0.458% | — | 0.096% 125.0K shares | — | — | $4.7B Mid Cap | Q4 2022 Held for 2y 11m | |
Biotechnology Healthcare | $4.2M 0.426% | +$4.2M New | — 245.0K shares | 0 → 245.0K +$4.2M | New | — — | Q3 2025 Held for 2 months | |
Unknown Unknown | $3.8M 0.382% | — | 3.16% 350.0K shares | — | — | $117.3M Micro Cap | Q2 2024 Held for 1y 5m | |
Medical - Devices Healthcare | $3.7M 0.377% | +$3.7M Bought | 0.169% 50.0K shares | — | — | $2.2B Mid Cap | Q3 2025 Held for 2 months | |
Biotechnology Healthcare | $3.4M 0.35% | +$2.6M Bought | 3.73% 2.7M shares | 667.5K → 2.7M +$2.6M | +296.99% | $92.4M Micro Cap | Q1 2025 Held for 8 months | |
Biotechnology Healthcare | $3.4M 0.343% | -$4.4M Sold | 0.034% 65.0K shares | 150.0K → 65.0K −$4.4M | -56.67% | $9.9B Mid Cap | Q1 2023 Held for 2y 8m |
